Exploring novel markers for coronary heart disease associated with systemic lupus erythematosus: A review
2024

Exploring markers for heart disease in lupus patients

publication Evidence: moderate

Author Information

Author(s): Linping Du, Yuqun Wang, Honglei Ma, Jiaheng Fan, Shiqi Wang, Junhong Liu, Xiaodong Wang

Primary Institution: Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Weifang, China

Hypothesis

The study investigates the relationship between systemic lupus erythematosus (SLE) and coronary heart disease (CHD), focusing on endothelial dysfunction and specific biomarkers.

Conclusion

Endothelial dysfunction plays a critical role in the increased risk of coronary heart disease among patients with systemic lupus erythematosus.

Supporting Evidence

  • SLE patients are at a higher risk of developing coronary heart disease compared to the general population.
  • Endothelial dysfunction is a key factor in the progression of coronary atherosclerosis in SLE patients.
  • Chronic inflammation and oxidative stress contribute to endothelial dysfunction and increased cardiovascular risk in SLE.

Takeaway

This study looks at how lupus can lead to heart problems by affecting the blood vessels, and it suggests new markers that could help doctors understand and treat these issues better.

Methodology

This is a narrative review that discusses various biomarkers and their roles in the relationship between SLE and CHD.

Limitations

The study highlights the need for longitudinal studies to better understand the relationship between CHD and endothelial progenitor cell damage in SLE patients.

Digital Object Identifier (DOI)

10.1097/MD.0000000000040773

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication